Predict Disease Risk from a Few Drops of Blood
theranOX's mail-in blood test can detect disease risks up to 10 years before symptoms appear, giving you the power to navigate your health journey before problems start.
Few Drops of Blood
20+ Disease Screen
£299 Introductory Price
80% Preventable
WHO confirms most chronic diseases can be prevented
Early Detection Critical
10-year window to intervene before symptoms appear
Personalised Recommendations
Actionable insights tailored to your specific health profile
Tech Developed in Oxford
Technology refined over a decade of university research
Simple Three-Step Process
Our painless, at-home testing process makes early disease detection convenient and accessible. No clinic visits or venous blood draws required, just test comfortably from your home.
Get Your Kit
Receive our mail-in test kit with a blood draw device (FDA/CE approved) that is painless. Device collects <0.5mL of blood.
Return Your Sample
Schedule a pickup or drop off your sample at a convenient location. Quick and hassle-free.
Get Your Results
We assess your results within 24 hours of receiving your sample, providing early warnings for dozens of chronic diseases.
Proven Technology Developed in Oxford
Our team has decades of deep domain expertise in proteomics, mass spectrometry, and clinical diagnostics. We use advanced mass spectrometry and synthetic biology to measure blood protein biomarkers that give a dynamic snapshot of current health and evolving disease risk.
We Only Measure Proteins
Over 80% of human diseases involve changes in protein expression or function like in Cancer, Cardiovascular or Neurological conditions.
Decade of Development
We have spent the better part of a decade perfecting the technique used by theranOX, combining advanced mass spectrometry with synthetic protein standards.
Developed by leading scientists in proteomics, leading clinicians, and predictive health technology experts
Validated Results
Our MVP was validated on aortic aneurysm (AA), a condition that typically goes undiagnosed until rupture. In our study of over 500 real-world patient samples:
We outperformed both imaging and traditional risk factor models in predicting aneurysm progression.
Expanding Our Capabilities
Many of these biomarkers are not specific to AA alone – they are shared across inflammatory, cardiovascular, renal, and metabolic pathways. This biological overlap underpins our expansion to 22+ diseases.
Predictive Blood Testing for Multiple Conditions
Our mail-in blood test provides early warnings for dozens of chronic diseases up to 10 years before symptoms appear. These conditions are validated in cohorts of over 45,000 individuals.
Dilated Cardiomyopathy
Other Cardiomyopathy
Primary Pulmonary Hypertension
Secondary Pulmonary Hypertension
Monoclonal Gammopathy
Multiple Myeloma
Non-Hodgkin Lymphoma
Primary Malignancy Lung
Primary Malignancy Prostate
Coeliac Disease
Liver Fibrosis & Cirrhosis
Diabetes Type I
Diabetes Type II
Hyperparathyroidism
Diabetic Ophthalmic Complications
Chronic Kidney Disease
End Stage Renal Disease
Menorrhagia & Polymenorrhoea
Diabetic Neurological Complications
Dementia
Chronic Obstructive Pulmonary Disease
Pulmonary Fibrosis
More conditions
More conditions
More conditions
Ready to Take Control of Your Health Journey?
Join our waitlist to be among the first to access our blood testing technology. Early detection means better outcomes.